The Magazine for Sleep Professionals
Friday, May 15, 2026
Bedfont Scientific Ltd., is celebrating a brighter 2022 as the U.S. Food and Drug Administration (FDA) cleared its NObreath FeNO monitor for use in monitoring airway inflammation. The NObreath®, which conforms to ATS and ERS guidelines1, is a portable, non-invasive device for the measurement of Fractional Exhaled Nitric Oxide (FeNO) […]
Nyxoah SA announced that the U.S. Food and Drug Administration (FDA) has approved the use of Nyxoah’s next-generation Genio® 2.1 system for use in the Company’s DREAM U.S. IDE pivotal study. Genio® 2.1’s upgrades are entirely related to the external components of the Genio® system, as the implantable stimulator remains […]
EnsoData, the leading AI health care company helping clinicians uncover disease while patients sleep, today announces the closing of a $20 million Series A extension led by Inspire Medical Systems, Inc. (“Inspire”), with participation from existing investors, including Zetta Venture Partners, Venture Investors, Supermoon Capital, Colle Capital, HealthX Ventures, M25 […]
According to MediPines, an increasing number of physicians have been utilizing a unique gas exchange analyzer technology to enhance recognition and diagnosis of pulmonary embolism (PE) in patients. The device, called the MediPines AGM100, is an FDA-cleared advanced pulmonary gas exchange technology that can precisely and non-invasively measure patients’ oxygen and […]
3B Medical, Inc., a manufacturer of sleep and respiratory products and services, announced that Clint Geffert has been named as president, commercial operations. The company also announced a name change and rebrand; it will know be known as React Health. Tom Pontzius, who has been acting president for both operations […]
This summer, Vitalograph is celebrating 21 years of empowering respiratory research through clinical trials services, building on its legacy of manufacturing respiratory diagnostic devices since 1963. Team members from the UK, USA and Ireland will be marking this milestone by fundraising for local respiratory charities in support of Vitalograph’s commitment […]
CerraCap Ventures, an early-stage VC specializing in cyber security, advanced analytics, and health-tech investments, announced its investment in Somnoware. This strategic investment from CerraCap Ventures is poised to accelerate Somnoware’s expansion in sleep, respiratory care, and additional healthcare markets. Somnoware’s mission is to reduce chronic respiratory disease healthcare costs and […]
Masimo marks its 33rd anniversary by announcing the limited market release of the W1™ health watch for consumers. The first of its kind, the Masimo W1 offers accurate, continuous measurements and actionable health insights – from the leader in hospital pulse oximetry – in a personal, discreet, lifestyle-friendly wrist-worn wearable. […]
Vitalograph® is delighted to announce this year’s first lunch and learn webinar series with the collaboration with the Asthma and Allergy Foundation of America. The topic is “PATIENT EXPERIENCE: INHALER USAGE,” and it will address common challenges related to inhaler usage and strategies for effective patient education on inhaler adherence […]
Inspire Medical Systems, Inc. (“Inspire”) reported equity investments in two private companies, EnsoData, Inc. in Madison, WI, and Ognomy Inc. in Buffalo, NY. EnsoData increases sleep lab capacity and efficiency with their FDA-approved sleep study analysis platform, EnsoSleep. Using waveform Artificial Intelligence (AI), EnsoSleep automates the scoring and analysis of […]
